Skip to main content
. 2012 Apr 3;54(11):1523–1535. doi: 10.1093/cid/cis213

Table 1.

Demographics, Clinical Factors, and Bivariate Analysis of Risk Factors Associated With Colonization of the Index Patient by the Index Patient’s Infecting Strain Type

Variable All, n = 350 (%) Colonized With Infecting Strain, n = 41 (%) Not Colonized With Infecting Strain, n = 309 (%) OR 95% CI P Value
Site
    Chicago 177 (51) 22 (53) 155 (50) 1.15 .60, 2.21 .67
    Los Angeles 173 (49) 19 (46) 154 (50)
Demographics
    Gender
        Female 180 (51) 26 (63) 154 (50) 1.75 .89, 3.42 .11
        Male 170 (49) 15 (37) 155 (50)
    Age
        Older adult (>65 yr) 15 (4) 2 (5) 13 (4) 1.30 .27, 6.22 .74
        Adult (19–65 yr) 180 (51) 19 (46) 161 (52) Ref
        Child (5–18 yr) 55 (16) 8 (20) 47 (15) 1.44 .59, 3.50 .42
        Younger child (<5 yr) 100 (29) 12 (29) 88 (28) 1.16 .54, 2.49 .71
    Ethnicity
        African-American 177 (51) 24 (58) 153 (50) 1.20 .34, 4.32 .78
        Caucasian 26 (7) 3 (7) 23 (7) Ref
        Hispanic 121 (35) 12 (29) 109 (35) 0.84 .22, 3.23 .81
        Other/mixed/unknown 26 (7) 2 (5) 24 (8) 0.64 .10, 4.18 .64
Clinical factors
    Charlson comorbidity score
        Mean ± SD 1 ± 2 1 ± 2 1 ± 2 0.92 .78, 1.08 .30
        Median (range) 0 (0–14) 0 (0–12) 0 (0–14)
    Comorbidities
        Diabetes 57 (16) 5 (12) 52 (17) 0.69 .26, 1.83 .45
        HIV infection 14 (5) 0 (0) 14 (14) NA NA .39
    In the past 12 mo:
        Had a previous skin infection 217 (62) 23 (56) 194 (63) 0.76 .39, 1.46 .41
        Undergone major surgery 88 (25) 12 (29) 76 (24) 1.27 .62, 2.61 .52
        Received dialysis 8 (2) 0 (0) 8 (3) NA NA .60
        Hospitalized 172 (49) 18 (44) 154 (50) 0.79 .41, 1.52 .48
    Days of hospitalization
        Mean ± SD 4 ± 18 3 ± 8 4 ± 19 0.99 .97, 1.02 .82
        Median (range) 0 (0–320) 0 (0–39) 0 (0–320)
    Any antibiotic exposure 237 (67) 24 (59) 213 (69) 0.64 .33, 1.24 .18
    Use of clindamycin 35 (10) 7 (18) 28 (9) 2.07 .86, 5.09 .16
    Use of TMP-SMX 37 (11) 3 (8) 34 (11) 0.65 .19, 2.18 .78
    Use of cephalexin 17 (5) 2 (5) 15 (5) 1.02 .23, 4.65 .99
    Use of immunosuppressant medications 70 (20) 9 (23) 61 (20) 1.15 .52, 2.57 .72
    Spent time living in a skilled nursing facility, rehabilitation center, or other type of group facility 8 (2) 2 (5) 6 (2) 2.68 .52, 13.74 .23
Epidemiologic factors
    Household density
        Mean ± SD 1.96 ± 1.08 1.94 ± 0.93 1.96 ± 1.10 0.99 .73, 1.35 .94
        Median (range) 1.73 (0.40–9.0) 1.66 (0.667–4.0) 2.0 (0.40–9.0)
    Homelessness in the past 12 mo 14 (4) 3 (7) 11 (3) 2.14 .57, 8.01 .22
    Cuts/scratches in the 30 d prior to index infection 143 (41) 19 (46) 124 (40) 1.29 .67, 2.48 .50
    Skin rash in the 90 d prior to index infection 60 (18) 14 (36) 46 (16) 2.97 1.44, 6.17 .002a
    Pets in the home, currently 156 (45) 15 (38) 141 (46) 0.702 .36, 1.38 .32
    Incarceration in the past 12 mo 9 (4) 0 (0) 9 (5) - - .60
    Illicit drug use in the past 12 mo 34 (10) 1 (2) 33 (11) 0.21 .03, 1.57 .15
    >1 sexual partner in the past 12 mo 25 (12) 3 (12) 22 (12) 1.02 .29, 3.70 .99
    In the past 3 mo:
        Showered at least once a day 39 (12) 4 (11) 35 (12) 0.91 .30, 2.71 .99
        Shared make-up with others 20 (7) 2 (5) 18 (7) 0.76 .17, 3.42 .99
        Shared bar soap with others 193 (57) 25 (63) 168 (56) 1.32 .67, 2.60 .42
        Shared clothes with others with washing 21 (6) 3 (7) 18 (6) 1.25 .35, 4.44 .73
        Shared towels with others 157 (46) 21 (51) 136 (45) 1.30 .67, 2.49 .43
        Wore clothes more than once without washing 166 (49) 23 (58) 143 (47) 1.48 .76, 2.87 .25
    Hand-washing frequency after using the bathroom
        Mean ± SD 2.6 ± 0.78 2.6 ± 0.80 2.6 ± 0.78 1.01 .66, 1.54 .97
        Median (range) 3 (0–3) 3 (0–3) 3 (0–3)
    Household cleaning scaleb
        Mean ± SD 16 ± 8 17 ± 8 16 ± 8 1.18 .62, 2.20 .61
        Median (range) 18 (0–35) 18 (0–33) 18 (0–35)
    Use of a gym 27 (14) 5 (14) 22 (9) 1.56 .55, 4.42 .38
    Participation in contact sports 83 (24) 11 (27) 72 (23) 1.21 .58, 2.53 .62
    Goes to day care 25 (19) 1 (7) 24 (21) 0.27 .03, 2.19 .30
    Use of public facilitiesc 76 (22) 12 (29) 64 (21) 1.58 .77, 3.27 .21
Strain-specific factors
    Infecting strain type categorization by the CDC case definition
        CA-MRSA 111 (32) 15 (37) 96 (31) 1.28 .65, 2.53 .92
        HA-MRSA 122 (35) 17 (42) 105 (34) Ref
        CA-MSSA 45 (13) 3 (7) 42 (14) 0.50 .15, 1.70 .29
        HA-MSSA 72 (20) 6 (15) 66 (21) 0.63 .26, 1.56 .28
        ST8-MRSA-Mec IV-PVL strain type 186 (53) 29 (71) 157 (51) 2.33 1.15, 4.75 .02
        PVL presence 266 (76) 33 (81) 233 (75) 0.74 .33, 1.67 .56
        SCCmec type IV 220 (63) 30 (73) 190 (62) 1.71 .82, 3.54 .17
    Other household members colonized with the infection strain type 81 (23) 21 (51) 60 (19) 4.36 2.22, 8.55 <.001d

Statistically significant relationships are bolded; NA indicates cannot be calculated due to zero cell.

Abbreviations: CA-MRSA, community-associated methicillin-resistant Staphylococcus aureus; CA-MSSA, community-associated methicillin-susceptible S. aureus; CDC, Centers for Disease Control and Prevention; CI, confidence inverval; HA-MRSA, healthcare-associated methicillin-resistant S. aureus; HA-MSSA, healthcare-associated methicillin-susceptible S. aureus; HIV, human immunodeficiency virus; OR, odds ratio; PVL, Panton-Valentine leukocidin; Ref, reference group; SD, standard deviation; TMP-SMX, trimethoprim-sulfamethoxazole.

a

Variable significant in multivariable analysis (OR, 2.9 [1.4–6.2]; P = .006).

b

Household cleaning is a measure of the frequency of cleaning for common household items, with higher values representing more frequent cleaning.

c

Use of public facilities is defined as use of a publicly available gym, locker room, shower, swimming pool, sauna, or Jacuzzi.

d

Variable significant in multivariable analysis (OR, 4.3 [2.1–8.6]; P < .001).